Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNotes PayablesPayablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Quantumzyme (QTZM) Common Equity (2016 - 2026)

Quantumzyme (QTZM) has 5 years of Common Equity data on record, last reported at -$490585.0 in Q4 2025.

  • For Q4 2025, Common Equity rose 2.03% year-over-year to -$490585.0; the TTM value through Oct 2025 reached -$490585.0, up 2.03%, while the annual FY2025 figure was -$440717.0, 0.0% changed from the prior year.
  • Common Equity reached -$490585.0 in Q4 2025 per QTZM's latest filing, down from -$440717.0 in the prior quarter.
  • Across five years, Common Equity topped out at -$402541.0 in Q2 2025 and bottomed at -$500740.0 in Q4 2024.